Abstract
Adenovirus vectors have attracted considerable interest over the past decade, with ongoing clinical development programs for applications ranging from replacement therapy for protein deficiencies to cancer therapeutics to prophylactic vaccines. Consequently, considerable product, process, analytical, and formulation development has been undertaken to support these programs. For example, “gutless” vectors have been developed in order to improve gene transfer capacity and durability of expression; new cell lines have been developed to minimize recombination events; production conditions have been optimized to improve volumetric productivities; analytical techniques and scaleable purification processes have advanced towards the goal of purified adenovirus becoming a “well-characterized biological”; and liquid formulations have been developed which maintain virus infectivity at 2–8°C for over 18 months. These and other advances in the production of adenovirus vectors are discussed in detail in this review. In addition, the needs for the next decade are highlighted.
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- AdV:
-
adenovirus
- Ad2:
-
adenovirus type 2
- Ad5:
-
adenovirus type 5
- AEX:
-
anion exchange
- ARM:
-
adenovirus reference material
- CPE:
-
cytopathic effect
- DELFIA:
-
dissociation-enhanced flouroimmunoassay
- ELISA:
-
enzyme-linked immunosorbent assay
- GMP:
-
good manufacturing practice
- hdAdV:
-
helper-dependent adenovirus
- HDEP:
-
helper-dependent E1-positive particle
- hpi:
-
hours post-infection
- MOI:
-
multiplicity of infection
- P/I:
-
particle-to-infectivity ratio
- Pfu:
-
plaque-forming unit
- RCA:
-
replication-competent adenovirus
- rpHPLC:
-
reversed-phase high performance liquid chromatography
- RSD:
-
relative standard deviation
- TCID50 :
-
tissue culture infectious dose at 50%
- QPCR:
-
quantitative polymerase chain reaction
- vp:
-
viral particles
References
St George JA (2003) Gene Ther 10:1135
Shiver JW, Emini EA (2004) Annu Rev Med 55:355
Morsy MA, Gu M, Motzel S, Zhao J, Lin J, Su Q, Allen H, Franlin L, Parks RJ, Graham FL, Kochanek S, Bett AJ, Caskey CT (1998) Proc Natl Acad Sci USA 95:7866
Edelstein ML, Abedi MR, Wixon J, Edelstein RM (2004) J Gene Med 6:597
Anonymous (2004) BioPharm Int 17:42
RAC (2002) Hum Gene Ther 13:3
Bauer SR, Pilaro AM, Weiss KD (2002) In: Curiel DT, Douglas JT (eds) Adenoviral vectors for gene therapy. Academic, New York, p 615
CBER (2000) Pharmacopeial Forum 26:56
Pinteric L, Taylor J (1962) Virology 18:359
Maizel JVJ, White DO, Scharff MD (1968) Virology 36:115
Sweeney JA, Hennessey JP Jr (2002) Virology 295:284
Blanche F, Cameron B, Barbot A, Ferrero L, Guillemin T, Guyot S, Somarriba S, Bisch D (2000) Gene Ther 7:1055
Shabram PW, Giroux DD, Goudreau AM, Gregory RJ, Horn MT, Huyghe BG, Liu XD, Nunnally MH, Sugarman BJ, Sutjipto S (1997) Hum Gene Ther 8:453
Lehmberg E, Traina JA, Chakel JA, Chang RJ, Parkman M, McCaman MT, Murakami PK, Lahidji V, Nelson JW, Hancock WS, Nestaas E, Pungor E Jr (1999) J Chromatogr B 732:411
Murakami P, McCaman MT (1999) Anal Biochem 274:283
Ma L, Bluyssen HA, De Raeymaeker M, Laurysens V, van der Beek N, Pavliska H, van Zonneveld AJ, Tomme P, van Es HH (2001) J Virol Methods 93:181
Saulnier P, Vidaud M, Gautier E, Motte N, Bellet D, Escudier B, Wilson D, Yver A (2003) J Virol Methods 114:55
Wang F, Patel DK, Antonello JM, Washabaugh MW, Kaslow DC, Shiver JW, Chirmule N (2003) Hum Gene Ther 14:25
Graham FL, Smiley J, Russell WC, Nairn R (1977) J Gen Virol 36:59
Graham FL, van der Eb AJ (1973) Virology 52:456
Wigand R, Kumel G (1977) Arch Virol 54:177
Darling AJ, Boose JA, Spaltro J (1998) Biologicals 26:105
Nyberg-Hoffman C, Shabram P, Li W, Giroux D, Aguilar Cordova E (1997) Nat Med 3:808
Allison AC, Valentine RC (1960) Biochim Biophys Acta 40:400
Wang F, Puddy AC, Mathis WC, Hager AG, Louis AA, McMackin JL, Xu J, Zhang Y, Tan CY, Schofield TS, Wolf JJ, Lewis JA (2005) Vaccine 23:4500
Weaver LS, Kadan MJ (2000) Methods 21:297
Lusky M, Christ M, Rittner K, Dieterle A, Dreyer D, Mourot B, Schultz H, Stoeckel F, Pavirani A, Mehtali M (1998) J Virol 72:2022
Ohtani S, Kagawa S, Tango Y, Umeoka T, Tokunaga N, Tsunemitsu Y, Roth JA, Taya Y, Tanaka N, Fujiwara T (2004) Mol Cancer Ther 3:93
Blanche F, Monegier B, Faucher D, Duchesne M, Audhuy F, Barbot A, Bouvier S, Daude G, Dubois H, Guillemin T, Maton L (2001) J Chromatogr A 921:39
Roitsch C, Achstetter T, Benchaibi M, Bonfils E, Cauet G, Gloeckler R, L'H te H, Keppi E, Nguyen M, Spehner D, Van Dorsselaer A, Malarme D (2001) J Chromatogr B 752:263
Fallaux FJ, Bout A, van der Velde I, van den Wollenberg DJ, Hehir KM, Keegan J, Auger C, Cramer SJ, van Ormondt H, van der Eb AJ, Valerio D, Hoeben RC (1998) Hum Gene Ther 9:1909
Nichols WW, Lardenoije R, Ledwith BJ, Brouwer K, Manam S, Vogels R, Kaslow D, Zuidgeest D, Bett AJ, Chen L, van der Kaaden M, Galloway SM, Hill RB, Machotka SV, Anderson CA, Lewis J, Martinez D, Lebron J, Russo C, Valerio D, Bout A (2002) In: Curiel DT, Douglas JT (eds) Adenoviral vectors for gene therapy. Academic, New York, p 129
Bondoc LL, Tang JCT (1997) Anal Biochem 247:443
Peden K (2001) VRBRAC Meeting on “Designer” Cells as Substrates for the Manufacture of Viral Vaccines, 16th May 2001, Gaithersburg, MD
Konz JO, Lee AL, Lewis JA, Sagar SL (2005) Biotechnol Prog 21:466
Seth P, Fitzgerald D, Ginsberg H, Willingham M, Pastan I (1984) Mol Cell Biol 4:1528
Vellekamp G, Porter FW, Sutjipto S, Cutler C, Bondoc L, Liu YH, Wylie D, Cannon Carlson S, Tang JT, Frei A, Voloch M, Zhuang S (2001) Hum Gene Ther 12:1923
Oliver CJ, Shortridge KF, Belyavin G (1976) Biochim Biophys Acta 437:589
Rexroad J, Wiethoff CM, Green AP, Kierstead TD, Scott MO, Middaugh CR (2003) J Pharm Sci 92:665
Bondoc LL, Fitzpatrick S (1998) J Ind Microbiol Biot 20:317
Horaud F (1994) Dev Biol Stand 82:113
Brown F, Griffiths E, Horaud F, Petricciani JC (eds) (1998) Dev Biol Std 93
CBER (1998) Guidance for industry: Guidance for human somatic cell therapy and gene therapy
Grachev V, Magrath D, Griffiths E, Petricciani JC, Chiu YY, Dobbelaer R, Gust I, Hardegree MC, Hayakawa T, Horaud F, Lubiniecki AS, Minor P, Montagnon B, Peetermans J, Ridgeway A, Robertson J, Schild G, Seamon KB (1998) Biologicals 26:175
USP (2000) US Pharmacopeia 2:138
FDA (1998) International Conference on Harmonization; Q5D: Guidance on quality of biotechnological=biological products: Derivation and characterization of cell substrates used for production of biotechnological=biological products (Notice). Food and Drug Administration, Rockville, MD
FDA (1998) International Conference on Harmonization; Q5A: Guidance on viral safety evaluation of biotechnology products derived from cell lines of human or animal origin (Notice). Food and Drug Administration, Rockville, MD
Tatalick LM, Gerard CJ, Takeya R, Price DN, Thorne BA, Wyatt LM, Anklesaria P (2005) Vaccine 23(20):2628–38
Prusiner SB (1998) P Natl Acad Sci USA 95:13363
Ironside J (1998) J Pathol 186:227
Butman BT (2004) In: 11th Annual Viral Vectors and Vaccines Conf, 8–11 November 2004, Williamsburg, VA
Cook J (2001) VRBRAC Meeting on “Designer” Cells as Substrates for the Manufacture of Viral Vaccines, 16th May 2001, Gaithersburg, MD
WHO (1987) Technical Report Series: Acceptability of cell substrates for the production of biologicals. World Health Organization, Geneva
Anderson SA, Hilleman MR, Warfield MS, Werner JH (1957) J Am Med Assoc 163:4
Hayflick L, Moorhead PS (1961) Exp Cell Res 25:585
Top FH Jr, Grossman RA, Bartelloni PJ, Segal HE, Dudding BA, Russell PK, Buescher EL (1971) J Infect Dis 124:148
Fletcher MA, Hessel L, Plotkin SA (1998) Dev Biol Stand 93:97
Berkner KL, Sharp PA (1983) Nucleic Acids Res 11:6003
Rich DP, Couture LA, Cardoza LM, Guiggio VM, Armentano D, Espino PC, Hehir K, Welsh MJ, Smith AE, Gregory RJ (1993) Hum Gene Ther 4:461
Haj-Ahmad Y, Graham FL (1986) J Virol 57:267
Lee MG, Abina MA, Haddada H, Perricaudet M (1995) Gene Ther 2:256
Ghosh-Choudhury G, Haj-Ahmad Y, Graham FL (1987) EMBO J 6:1733
Youil R, Toner TJ, Su Q, Casimiro D, Shiver JW, Chen L, Bett AJ, Rogers BM, Burden EC, Tang A, Chen M, Emini EA, Kaslow DC, Aunins JG, Altaras NE (2003) Hum Gene Ther 14:1017
Wivel N, Gao G, Wilson J (1999) The development of human gene therapy. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, p 87
Yeh P, Perricaudet M (1997) FASEB J 11:615
Fang B, Koch P, Roth JA (1997) J Virol 71:4798
Zhou H, O'Neal W, Morral N, Beaudet AL (1996) J Virol 70:7030
Gorziglia MI, Kadan MJ, Yei S, Lim J, Lee GM, Luthra R, Trapnell BC (1996) J Virol 70:4173
Amalfitano A, Chamberlain JS (1997) Gene Ther 4:258
Langer SJ, Schaack J (1996) Virology 221:172
Armentano D, Zabner J, Sacks C, Sookdeo CC, Smith MP, St George JA, Wadsworth SC, Smith AE, Gregory RJ (1997) J Virol 71:2408
Baxi MK, Robertson J, Babiuk LA, Tikoo SK (2001) Virology 290:153
Gao GP, Yang Y, Wilson JM (1996) J Virol 70:8934
Krougliak V, Graham FL (1995) Hum Gene Ther 6:1575
Gorziglia MI, Lapcevich C, Roy S, Kang Q, Kadan M, Wu V, Pechan P, Kaleko M (1999) J Virol 73:6048
Massie B, Mosser D, Koutromannis M, Vitte-Mony I, Lamoreaux L, Couture F, Paquet L, Guibault D, Dionne J, Chahla D, Joelicoeur P, Langelier Y (1998) Cytotechnology 28:53
Edholm D, Molin M, Bajak E, Akusjarvi G (2001) J Virol 75:9579
Tietge UJ, Kozarsky KF, Donahee MH, Rader DJ (2003) J Gene Med 5:567
Gotoh A, Ko SC, Shirakawa T, Cheon J, Kao C, Miyamoto T, Gardner TA, Ho LJ, Cleutjens CB, Trapman J, Graham FL, Chung LW (1998) J Urol 160:220
Morelli AE, Larregina AT, Smith-Arica J, Dewey RA, Southgate TD, Ambar B, Fontana A, Castro MG, Lowenstein PR (1999) J Gen Virol 80(Pt 3):571
Glenn GM, Chatterjee S (2001) Cancer Gene Ther 8:566
Rodriguez R, Choudhury W (2003) PCT Patent Application W=O 2003087348
Kirn D, Martuza RL, Zwiebel J (2001) Nat Med 7:781
Sunamura M, Hamada H, Motoi F, Oonuma M, Abe H, Saitoh Y, Hoshida T, Ottomo S, Omura N, Matsuno S (2004) Pancreas 28:326
Geoerger B, Vassal G, Opolon P, Dirven CM, Morizet J, Laudani L, Grill J, Giaccone G, Vandertop WP, Gerritsen WR, van Beusechem VW (2004) Cancer Res 64:5753
Maemondo M, Saijo Y, Narumi K, Kikuchi T, Usui K, Tazawa R, Matsumoto K, Nakamura T, Sasaki K, Takahashi M, Niitsu Y, Nukiwa T (2004) Cancer Res 64:4611
McCormick F (2001) Nat Rev Cancer 1:130
Kanerva A, Hemminka A (2004) Drugs Future 29:359
Yuk IH, Olsen MM, Geyer S, Forestell SP (2004) Biotechnol Bioeng 86:637
Oualikene W, Lamoureux L, Weber JM, Massie B (2000) Hum Gene Ther 11:1341
Sprangers MC, Lakhai W, Koudstaal W, Verhoeven M, Koel BF, Vogels R, Goudsmit J, Havenga MJ, Kostense S (2003) J Clin Microbiol 41:5046
Aste-Amezaga M, Bett AJ, Wang F, Casimiro DR, Antonello JM, Patel DK, Dell EC, Franlin LL, Dougherty NM, Bennett PS, Perry HC, Davies ME, Shiver JW, Keller PM, Yeager MD (2004) Hum Gene Ther 15:293
Glasgow JN, Bauerschmitz GJ, Curiel DT, Hemminki A (2004) Curr Gene Ther 4:1
Alvarez RD, Barnes MN, Gomez-Navarro J, Wang M, Strong TV, Arafat W, Arani RB, Johnson MR, Roberts BL, Siegal GP, Curiel DT (2000) Clin Cancer Res 6:3081
Gao W, Robbins PD, Gambotto A (2003) Gene Ther 10:1941
Reddy PS, Ganesh S, Limbach MP, Brann T, Pinkstaff A, Kaloss M, Kaleko M, Connelly S (2003) Virology 311:384
Yun CO, Cho EA, Song JJ, Kang DB, Kim E, Sohn JH, Kim JH (2003) Hum Gene Ther 14:1643
Cashman SM, Morris DJ, Kumar-Singh R (2004) Virology 324:129
Ophorst OJ, Kostense S, Goudsmit J, De Swart RL, Verhaagh S, Zakhartchouk A, Van Meijer M, Sprangers M, Van Amerongen G, Yuksel S, Osterhaus AD, Havenga MJ (2004) Vaccine 22:3035
Pereboeva L, Komarova S, Mahasreshti PJ, Curiel DT (2004) Virus Res 105:35
Nicol CG, Graham D, Miller WH, White SJ, Smith TA, Nicklin SA, Stevenson SC, Baker AH (2004) Mol Ther 10:344
Youil R, Toner TJ, Su Q, Chen M, Tang A, Bett AJ, Casimiro D (2002) Hum Gene Ther 13:311
Varga CM, Wickham TJ, Lauffenburger DA (2000) Biotechnol Bioeng 70:593
Worgall S, Busch A, Rivara M, Bonnyay D, Leopold PL, Merritt R, Hackett NR, Rovelink PW, Bruder JT, Wickham TJ, Kovesdi I, Crystal RG (2004) J Virol 78:2572
Nicklin SA, Baker AH (2002) Curr Gene Ther 2:273
Ferreira T, Alves P, Aunins J, Carrondo M (2005) Gene Ther 12:S73–S83
Wu Q, Tikoo SK (2004) Virus Res 99:9
Kremer EJ (2004) J Gene Med 6(Suppl 1):S139
Renaut L, Colin M, Leite JP, Benko M, D'Halluin JC (2004) Virology 321:189
Glasgow JN, Kremer EJ, Hemminki A, Siegal GP, Douglas JT, Curiel DT (2004) Virology 324:103
Roy S, Gao G, Lu Y, Zhou X, Lock M, Calcedo R, Wilson JM (2004) Hum Gene Ther 15:519
Farina SF, Gao GP, Xiang ZQ, Rux JJ, Burnett RM, Alvira MR, Marsh J, Ertl HC, Wilson JM (2001) J Virol 75:11603
Einfeld DA, Brough DE, Roelvink PW, Kovesdi I, Wickham TJ (1999) J Virol 73:9130
Orlando JS, Ornelles DA (2002) J Virol 76:1475
Lochmuller H, Jani A, Huard J, Prescott S, Simoneau M, Massie B, Karpati G, Acsadi G (1994) Hum Gene Ther 5:1485
Robert JJ, Gauffeny I, Maccario J, Jullien C, Benoit P, Vigne E, Crouzet J, Perricaudet M, Yeh P (2001) Gene Ther 8:1713
Hehir KM, Armentano D, Cardoza LM, Choquette TL, Berthelette PB, White GA, Couture LA, Everton MB, Keegan J, Martin JM, Pratt DA, Smith MP, Smith AE, Wadsworth SC (1996) J Virol 70:8459
Fallaux F, Van der Velde I, Kranenburg O, Cramer S, Houweling A, van Ormondt H, Bout A, Hoeben R, Valerio D, van der Eb A (1995) Gene Ther 2:S7
Schiedner G, Hertel S, Kochanek S (2000) Hum Gene Ther 11:2105
Gao GP, Engdahl RK, Wilson JM (2000) Hum Gene Ther 11:213
Massie B (1999) U.S. Patent 5,891,690
Murakami P, Havenga M, Fawaz F, Vogels R, Marzio G, Pungor E, Files J, Do L, Goudsmit J, McCaman M (2004) J Virol 78:6200
Murakami P, Pungor E, Files J, Do L, van Rijnsoever R, Vogels R, Bout A, McCaman M (2002) Hum Gene Ther 13:909
Ling WL, Longley RL, Brassard DL, Armstrong L, Schaefer EJ (2002) Gene Ther 9:907
Shaw G, Morse S, Ararat M, Graham FL (2002) FASEB J 16:869
Kochanek S, Schiedner G, Volpers C (2001) Curr Opin Mol Ther 3:454
Bett AJ, Prevec L, Graham FL (1993) J Virol 67:5911
Alemany R, Dai Y, Lou YC, Sethi E, Prokopenko E, Josephs SF, Zhang WW (1997) J Virol Methods 68:147
Parks RJ, Chen L, Anton M, Sankar U, Rudnicki MA, Graham FL (1996) P Natl Acad Sci USA 93:13565
Ng P, Parks RJ, Cummings DT, Evelegh CM, Sankar U, Graham FL (1999) Hum Gene Ther 10:2667
Zou L, Zhou H, Pastore L, Yang K (2000) Mol Ther 2:105
Gilbert R, Dudley RW, Liu AB, Petrof BJ, Nalbantoglu J, Karpati G (2003) Hum Mol Genet 12:1287
Kim IH, Jozkowicz A, Piedra PA, Oka K, Chan L (2001) P Natl Acad Sci USA 98:13282
Maione D, Wiznerowicz M, Delmastro P, Cortese R, Ciliberto G, La Monica N, Savino R (2000) Hum Gene Ther 11:859
Schiedner G, Morral N, Parks RJ, Wu Y, Koopmans SC, Langston C, Graham FL, Beaudet AL, Kochanek S (1998) Nat Genet 18:180
Abremski K, Hoess R (1984) J Biol Chem 259:1509
Sakhuja K, Reddy PS, Ganesh S, Cantaniag F, Pattison S, Limbach P, Kayda DB, Kadan MJ, Kaleko M, Connelly S (2003) Hum Gene Ther 14:243
Umana P, Gerdes CA, Stone D, Davis JR, Ward D, Castro MG, Lowenstein PR (2001) Nat Biotechnol 19:582
Parks RJ, Bramson JL, Wan Y, Addison CL, Graham FL (1999) J Virol 73:8027
Sandig V, Youil R, Bett AJ, Franlin LL, Oshima M, Maione D, Wang F, Metzker ML, Savino R, Caskey CT (2000) P Natl Acad Sci USA 97:1002
Ng P, Evelegh C, Cummings D, Graham FL (2002) J Virol 76:4181
Maranga L, Aunins J, Zhou W (2005) Biotechnol Bioeng 90(5):645–655
Heilman CA, Rouse H (1980) Virology 105:159
Radlett P, Pay T, Garland A (1985) Dev Biol Stand 60:163
Shenk TE (2001) In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams & Wilkins, Philadelphia, PA, p 2265
Mittereder N, March KL, Trapnell BC (1996) J Virol 70:7498
Dee K, Shuler M, Wood A (1997) Biotechnol Bioeng 54:191
Peshwa M, Kyung Y-S, McClure D, Hu W-S (1993) Biotechnol Bioeng 41:179
Dee K, Shuler M, Wood A (1997) Biotechnol Bioeng 54:206
Giroux D, Goudreau AM, Ramachandra M, Shabram P (1999) US Patent 5,994,134
Condon RGG, Connelly NV, Frei A, Glowacki E, Yabannavar V, Batandolo S (2004) US Patent 6,783,983
Zhang S, Pham H, Senesac P, Clarke P (2004) In: 11th Annual Viral Vectors and Vaccines Conf, 8–11 November 2004, Williamsburg, VA
Zhang S, Thwin C, Wu Z, Cho T (2001) US Patent 6,194,191 B1
Xie LZ, Metallo C, Warren J, Pilbrough W, Peltier J, Zhong T, Pikus L, Yancy A, Leung J, Aunins JG, Zhou WC (2003) Biotechnol Bioeng 83:45
Monica TJ, Montgomery T, Ayala JL, Schoofs GM, Whiteley EM, Roth G, Garbutt JJ, Harvey S, Castillo FJ (2000) Biotechnol Prog 16:866
Monica TJ, Whitely E, Castillo F, Tan M, Tse S, Ja G, Rodriguez E, Pungor E, Nastaas E (2000) In: 7th Annual Viral Vectors and Vaccines Conf, 6–9 November 2000, Lake Tahoe, NV
Gentile M-P, Altaras NE, Youil R, Toner TJ, Aunins J, Zhou W (2002) In: 224th American Chemical Society National Meeting, 18–22 August 2002, Boston, MA
Jardon M, Garnier A (2003) Biotechnol Prog 19:202
Xie L, Pilbrough W, Metallo C, Zhong T, Pikus L, Leung J, Aunins JG, Zhou W (2002) Biotechnol Bioeng 80:569
Xie L, Pilbrough W, Metallo C, Warren J, Peltier J, Aunins J (2002) In: 8th Cell Culture Engineering Conf, 1–6 April 2002, Snowmass, CO
Nadeau I, Gilbert PA, Jacob D, Perrier M, Kamen A (2002) Biotechnol Bioeng 77:91
Nadeau I, Kamen A (2003) Biotechnol Adv 20:475
Schoofs G, Monica TJ, Ayala J, Horwitz J, Montgomery T, Roth G, Castillo FJ (1998) Cytotechnology 28:81
Iyer P, Ostrove JM, Vacante D (1999) Cytotechnology 30:169
Merten OW, Manuguerra JC, Hannoun C, van der Werf S (1999) Dev Biol Stand 98:23
Frazzati-Gallina NM, Paoli RL, Mourao-Fuches RM, Jorge SA, Pereira CA (2001) J Biotechnol 92:67
Garnier A, Cote J, Nadeau I, Kamen A, Massie B (1994) Cytotechnology 15:145
Nadeau I, Garnier A, Cote J, Massie B, Chavarie C, Kamen A (1996) Biotechnol Bioeng 51:613
Lee YY, Yap MG, Hu WS, Wong KT (2003) Biotechnol Prog 19:501
Henry O, Dormond E, Perrier M, Kamen A (2004) Biotechnol Bioeng 86:765
Blumentals I, Warren J, Scott R, Otero JM (2004) In: 9th Cell Culture Engineering Conf, 7–13 March 2004, Cancun, Mexico
Klemperer HG, Pereira HG (1959) Virology 9:536
Haruna I, Yaoi H, Kono R, Watanabe I (1961) Virology 13:264
Philipson L, Albertsson PA, Frick G (1960) Virology 11:553
Philipson L (1960) Virology 10:459
Green M, Pina M (1963) Virology 20:199
Kanegae Y, Makimura M, Saito I (1994) Jpn J Med Sci Biol 47:157
Huyghe BG, Liu X, Sutjipto S, Sugarman BJ, Horn MT, Shepard HM, Scandella CJ, Shabram P (1995) Hum Gene Ther 6:1403
Tang JC, Vellekamp G, Bondoc LL (2001) US Patent 6,261,823 B1
Cannon-Carlson SV, Cutler C, Vellekamp GJ, Voloch M (2002) US Patent Application 2002=0064860 A1
Murphy C, Nahapetian A, Iyer P, Gore N, Fogle P, Moreland T, Wilhelm E (1998) 5th Annual Viral Vectors and Vaccines Conf, 16–19 November, 1998, Williamsburg, VA
Green AP, Huang JJ, Scott MO, Kierstead TD, Beaupre I, Gao GP, Wilson JM (2002) Hum Gene Ther 13:1921
Goerke AR, To BCS, Lee AL, Sagar SL, Konz JO (2005) Biotechnol Bioeng 91(1):12–21
Eckhardt BM, Oeswein JQ, Bewley TA (1991) Pharm Res 8:1360
Tollefson AE, Scaria A, Hermiston TW, Ryerse JS, Wold LJ, Wold WS (1996) J Virol 70:2296
Shabram P, Vellekamp G, Scandella C (2002) In: Curiel DT, Douglas JT (eds) Adenoviral vectors for gene therapy. Academic, New York, p 167
Hughes BS, Kalscheur M, Chen J, Subramanian S, Zhou W, Altaras NE (2004) 227th American Chemical Society National Meeting, 27 March–1 April 2004, Anaheim, CA
Hagen AJ, Aboud RA, DePhillips PA, Oliver CN, Orella CJ, Sitrin RD (1996) Biotechnol Appl Biochem 23:209
Singhvi R, Schorr C, O'Hara C, Xie L, Wang DIC (1996) BioPharm 9:35
Yavorsky D, Blanck R, Lambalot C, Brunkow R (2003) Pharmaceut Technol March:62
Guttman-Bass N, Armon R (1983) Appl Environ Microbiol 45:850
Sobsey MD, Oglesbee SE, Wait DA (1985) Appl Environ Microbiol 50:1457
Enriquez CE, Gerba CP (1995) Water Res 29:2554
Hagen AJ, Oliver CN, Sitrin RD (1996) Biotechnol Prog 12:406
Schagen FH, Moor AC, Cheong SC, Cramer SJ, van Ormondt H, van der Eb AJ, Dubbelman TM, Hoeben RC (1999) Gene Ther 6:873
Schagen FH, Rademaker HJ, Rabelink MJ, van Ormondt H, Fallaux FJ, van der Eb AJ, Hoeben RC (2000) Gene Ther 7:1570
Stilwell JL, McCarty DM, Negishi A, Superfine R, Samulski RJ (2003) J Virol 77:12881
Sagar SL, Chau YG, Watson MP, Lee AL (2002) In: Rathore AS, Vella G (eds) Scale-up and optimization in preparative chromatography: Principles and biopharmaceutical applications, vol 88. Marcel Dekker, New York, p 251
DePhillips P, Lenhoff AM (2000) J Chromatogr A 883:39
Burness ATH (1969) In: Habel K, Salzman NP (eds) Fundamental techniques in virology. Academic, New York, p 94
Kraiselbuld EP, Gage I, Weissbach A (1975) J Mol Biol 97:533
Puvion-Dutilleul F, Besse S, Pichard E, Cajean-Feroldi C (1998) Biol Cell 90:5
Croyle MA, Gerding K, Quick KS (2003) Bioprocess J 2:35
Galdiero F (1979) Arch Virol 59:99
O'Grady J, Losikoff A, Poiley J, Fickett D, Oliver C (1996) Dev Biol Stand 88:319
Hughes B, Bradburne A, Sheppard A, Young D (1996) Dev Biol Stand 88:91
Sakurai F, Mizuguchi H, Yamaguchi T, Hayakawa T (2003) Mol Ther 8:813
Havenga MJ, Lemckert AA, Ophorst OJ, van Meijer M, Germeraad WT, Grimbergen J, van Den Doel MA, Vogels R, van Deutekom J, Janson AA, de Bruijn JD, Uytdehaag F, Quax PH, Logtenberg T, Mehtali M, Bout A (2002) J Virol 76:4612
Roelvink PW, Lizonova A, Lee JG, Li Y, Bergelson JM, Finberg RW, Brough DE, Kovesdi I, Wickham TJ (1998) J Virol 72:7909
Mei YF, Lindman K, Wadell G (2002) Virology 295:30
Barouch DH, Pau MG, Custers JH, Koudstaal W, Kostense S, Havenga MJ, Truitt DM, Sumida SM, Kishko MG, Arthur JC, Korioth-Schmitz B, Newberg MH, Gorgone DA, Lifton MA, Panicali DL, Nabel GJ, Letvin NL, Goudsmit J (2004) J Immunol 172:6290
Green NM, Wrigley NG, Russell WC, Martin SR, McLachlan AD (1983) EMBO J 2:1357
Stouten PF, Sander C, Ruigrok RW, Cusack S (1992) J Mol Biol 226:1073
Shayakhmetov DM, Lieber A (2000) J Virol 74:10274
Minor PD (2000) Virology 268:231
Hoganson DK, Ma JC, Asato L, Ong M, Printz MA, Huyghe BG, Sosnowski BA, D'Andrea MJ (2002) Bioprocessing: Tech Dev Opp 1:43
Croyle MA, Roessler BJ, Davidson BL, Hilfinger JM, Amidon GL (1998) Pharm Dev Technol 3:373
Casto BC, Hammon WM (1966) P Soc Exp Biol Med 122:1216
Russell WC, Valentine RC, Pereira HG (1967) J Gen Virol 1:509
Yamamoto T (1967) Can J Microbiol 13:1139
Wigand R, Bachmann P, Brandner G (1981) Arch Virol 69:61
Wallis C, Melnick JL (1962) Virology 16:504
Melnick JL, Wallis C (1963) P Soc Exp Biol Med 112:894
Rombaut B, Verheyden B, Andries K, Boeye A (1994) J Virol 68:6454
Burke CJ, Hsu TA, Volkin DB (1999) Crit Rev Ther Drug 16:1
Sene C (1998) PCT Patent Application WO 98=02522
Shih S-J, Mcglennon KR, Moody D (2000) PCT Patent Application WO 00=09675
Evans RK, Nawrocki DK, Isopi LA, Williams DM, Casimiro DR, Chin S, Chen M, Zhu DM, Shiver JW, Volkin DB (2004) J Pharm Sci 93:2458
Grant RA, Hiremath CN, Filman DJ, Syed R, Andries K, Hogle JM (1994) Curr Biol 4:784
Andries K, Rombaut B, Dewindt B, Boeye A (1994) J Virol 68:3397
Dimmock NJ (1967) Virology 31:338
Green M, Wold WS (1979) Methods Enzymol 58:425
Blanche F, Shih S-J (2000) PCT Patent Application WO 00=61726
Blanche F, Cameron B, Somarriba S, Maton L, Barbot A, Guillemin T (2001) Anal Biochem 297:1
Croyle MA, Cheng X, Wilson JM (2001) Gene Ther 8:1281
Frei A, Kwan HKH, Sandweiss VE, Vellekamp GJ, Yuen P-H, Bondoc LL, Porter FWP, Tang JC-T, Ihnat P (2003) US Patent Application 0157066 A1
Kovesdi I, Ransom SC (2003) US Patent Application 0153065 A1
Wu Z, Zhang S (2004) US Patent 6,689,600 B1
Jumaa M, Muller BW (1999) Eur J Pharm Sci 9:207
Reich I, Schnaare R, Sugita ET (1995) In: Gennaro AR, Chase GD, Marderosian AD, Hanson GR, Hussar DA, Medwick T, Rippie EG, Schwartz JB, White HS, Zink GL (eds) Remmington: the science and practice of pharmacy. Mack Printing Co, Easton, PA, p 613
Li S, Schoneich C, Borchardt RT (1995) Biotechnol Bioeng 48:490
Middaugh CR, Evans RK, Montgomery DL, Casimiro DR (1998) J Pharm Sci 87:130
Evans RK, Xu Z, Bohannon KE, Wang B, Bruner MW, Volkin DB (2000) J Pharm Sci 89:76
Fujioka R, Kurtz H, Ackermann WW (1969) P Soc Exp Biol Med 132:825
Melnick JL (1994) In: Plotkin SA, Mortimer EA (eds) Vaccines. WB Saunders, Philadelphia, PA
Hannan C, Raptis LH, Dery CV, Weber J (1983) Intervirology 19:213
Setiawan K, Cameron FH (2003) PCT Patent Application WO 03=049763
Lehmberg E, Pungor E (2003) US Patent Application 0232018 A1
Acknowledgments
We thank coworkers who contributed to the generation of unpublished data presented in this work (Fig. 2: Marie-Pierre Gentile and Gina Cremona; Fig. 4: Matthew Kalscheur, Marie-Pierre Gentile, and Benjamin Hughes; Figs. 8 and 9: Denise Nawrocki, Lynne Isopi, and Donna Williams) and Drs. Angelica Meneses-Acosta and Olivier Henry for providing data and assistance with Figs. 5 and 6. We also thank Dr. John Lewis and Dr. Katey Einterz Owen for reviewing portions of this manuscript and providing helpful suggestions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this chapter
Cite this chapter
Altaras, N.E., Aunins, J.G., Evans, R.K., Kamen, A., Konz, J.O., Wolf, J.J. Production and Formulation of Adenovirus Vectors. In: Gene Therapy and Gene Delivery Systems. Advances in Biochemical Engineering/Biotechnology, vol 99. Springer, Berlin, Heidelberg. https://doi.org/10.1007/10_008
Download citation
DOI: https://doi.org/10.1007/10_008
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-28404-8
Online ISBN: 978-3-540-32412-6
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)